staurosporine has been researched along with Lymphoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, LV; Coutinho, FP; Damani, TT; Dunn, AC; McLellan, AD; Muhsin-Sharafaldine, MR; Saunderson, SC | 1 |
| Conley, BA; Dancey, J; Doroshow, JH; Figg, WD; Gardner, ER; Gutierrez, ME; Kummar, S; Melillo, G; Murgo, AJ; Sausville, EA | 1 |
| Cheson, BD | 1 |
| Shacter, E; Zhang, B; Zhang, Y | 1 |
| Amaral, SM; Anastasiadou, E; Boulton, CL; Curley, DP; Duclos, N; Fabbro, D; Gilliland, DG; Griffin, JD; Huntly, BJ; Joseph, SW; Lee, BH; Williams, IR | 1 |
| Carey, GB; Liberti, JP | 1 |
| Louahed, J; Renauld, JC; Van Snick, J; Vink, A | 1 |
| Cohen, R; Gertler, A; Horn, S | 1 |
| Elberg, G; Li, J; Shechter, Y | 1 |
| Sochanowicz, B; Szumiel, I | 1 |
| Joshi, B; Li, L; Tang, DG; Zhu, Z | 1 |
| Dai, Y; Decker, R; Dent, P; Grant, S; Harvey, S; Kramer, L; Schaefer, G; Tang, L | 1 |
| Augereau, JM; Gleye, J; Herbert, JM; Maffrand, JP | 1 |
1 review(s) available for staurosporine and Lymphoma
| Article | Year |
|---|---|
Hematologic malignancies: new developments and future treatments.
Topics: Adenine Nucleotides; Alemtuzumab; Alkaloids; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Cell Cycle; Cell Survival; Clofarabine; Cytosine; Dioxolanes; Flavonoids; Hematologic Neoplasms; Humans; Immunoconjugates; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; NF-kappa B; Nitrogen Mustard Compounds; Oligonucleotides, Antisense; Peptide Hydrolases; Piperidines; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Remission Induction; Rituximab; Staurosporine; Thionucleotides | 2002 |
1 trial(s) available for staurosporine and Lymphoma
| Article | Year |
|---|---|
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasms; Prednisone; Staurosporine; Young Adult | 2010 |
11 other study(ies) available for staurosporine and Lymphoma
| Article | Year |
|---|---|
The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
Topics: Animals; Apoptosis; Biotinylation; Cell Line, Tumor; Cytotoxicity, Immunologic; Doxorubicin; Extracellular Vesicles; Lymphoma; Mice, Inbred C57BL; Sialic Acid Binding Ig-like Lectin 1; Staurosporine; T-Lymphocytes, Cytotoxic | 2016 |
Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.
Topics: Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cytoskeleton; Down-Regulation; Etoposide; Genetic Vectors; Humans; Lymphoma; Models, Molecular; Mutagenesis, Site-Directed; Mutation; p21-Activated Kinases; Plasmids; Protein Binding; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; rac GTP-Binding Proteins; Recombinant Proteins; Signal Transduction; Staurosporine; Time Factors; Transfection; Tumor Cells, Cultured | 2003 |
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model.
Topics: Animals; Disease Models, Animal; fms-Like Tyrosine Kinase 3; Gene Duplication; Humans; Leukemia; Lymphoma; Mice; Mice, Transgenic; Mutation; Myeloproliferative Disorders; Phenotype; Promoter Regions, Genetic; Protein Kinase C; Staurosporine | 2005 |
Stimulation of receptor-associated kinase, tyrosine kinase, and MAP kinase is required for prolactin-mediated macromolecular biosynthesis and mitogenesis in Nb2 lymphoma.
Topics: Alkaloids; Amino Acid Sequence; Animals; Calcium-Calmodulin-Dependent Protein Kinases; DNA; Genistein; Isoflavones; Janus Kinase 2; Lymphocyte Activation; Lymphoma; Molecular Sequence Data; Polyenes; Prolactin; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Ribosomal Protein S6; Ribosomal Protein S6 Kinases; Ribosomal Proteins; Signal Transduction; Sirolimus; Staurosporine; T-Lymphocytes; Tumor Cells, Cultured | 1995 |
Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas.
Topics: Alkaloids; Animals; Apoptosis; Cell Division; Cyclosporine; Dexamethasone; DNA Damage; DNA, Neoplasm; Interleukin-2; Interleukin-4; Interleukin-7; Interleukin-9; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasms, Radiation-Induced; Protein Kinase C; Signal Transduction; Staurosporine; Thymus Neoplasms; Tumor Cells, Cultured | 1995 |
Regulation of heat-shock protein (hsp70) gene expression by hGH and IL2 in rat Nb2 lymphoma cells.
Topics: Alkaloids; Animals; Blotting, Northern; Cell Division; Cholera Toxin; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation, Neoplastic; Growth Hormone; GTP-Binding Proteins; HSP70 Heat-Shock Proteins; Interleukin-2; Lymphoma; Pertussis Toxin; Protein Kinase C; Rats; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1994 |
Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity.
Topics: Adipocytes; Adipose Tissue; Alkaloids; Animals; Brain; Cell-Free System; Cells, Cultured; Cytosol; Insulin; Kinetics; Liver; Lymphoma; Male; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Receptor Protein-Tyrosine Kinases; Receptor, IGF Type 1; Receptor, Insulin; Staurosporine; Vanadates | 1994 |
Arachidonic acid metabolism in murine lymphoma cell sublines differing in radiation sensitivity.
Topics: Animals; Arachidonic Acid; Calcimycin; Cell Line; Hydrogen Peroxide; Hydroxyeicosatetraenoic Acids; Ionomycin; Lymphoma; Mice; Phospholipids; Prostaglandins; Radiation Tolerance; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; X-Rays | 1996 |
Apoptosis in the absence of cytochrome c accumulation in the cytosol.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Biotin; Bleomycin; Blotting, Western; Camptothecin; Cytochrome c Group; Cytosol; Enzyme Inhibitors; Etoposide; Humans; Hydroxamic Acids; Lymphoma; Microscopy, Fluorescence; Mitochondria; Phalloidine; Poly(ADP-ribose) Polymerases; Staurosporine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine | 1998 |
Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Arabinonucleotides; Blotting, Western; Drug Interactions; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia; Lymphoma; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Staurosporine; U937 Cells; Vidarabine | 2001 |
Chelerythrine is a potent and specific inhibitor of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Antibiotics, Antineoplastic; Benzophenanthridines; Binding, Competitive; Brain; Cell Transformation, Neoplastic; Isoquinolines; Kinetics; Leukemia L1210; Lymphoma; Phenanthridines; Piperazines; Protein Kinase C; Rats; Staurosporine; Tumor Cells, Cultured | 1990 |